Align Technology, Inc. vs West Pharmaceutical Services, I
A head-to-head of Align Technology, Inc. (ALGN) and West Pharmaceutical Services, I (WST) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | ALGN | WST |
|---|---|---|
| Market Cap | $13.66B | $22.35B |
| P/E (TTM) | 27.13 | 42.20 |
| Forward P/E | 12.99 | 34.01 |
| P/S | 3.33 | 6.48 |
| P/B | 2.79 | 7.66 |
| EV/EBITDA | 14.35 | 24.06 |
| Dividend Yield | — | 0.27% |
| Profit Margin | 10.50% | 16.85% |
| Gross Margin | 67.19% | 35.89% |
| Operating Margin | 14.51% | 20.09% |
| Revenue Growth (YoY) | +6.21% | +21.01% |
| FCF Yield | 4.27% | 2.19% |
| Debt / Equity | 2.80 | 7.50 |
| Current Ratio | 1.39 | 2.71 |
Share:
Compare Align Technology, Inc. with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.